Key result
Fenestrated Amplatzer septal occluder implantation was safely accomplished with 0% complications in 15 high-risk ASD patients, improving NYHA class and decreasing pulmonary artery pressure.
Why the study?
Does a fenestrated septal occluder safely improve symptoms and hemodynamics in elderly ASD patients with pulmonary hypertension and/or right heart failure?
Does a fenestrated septal occluder safely improve symptoms and hemodynamics in elderly ASD patients with pulmonary hypertension and/or right heart failure?
Fenestrated ASD occlusion is a safe and feasible approach for high-risk elderly patients with pulmonary hypertension or right heart failure, preventing post-procedural heart failure deterioration.
No takes yet. Share an insight, caveat, or question.
May support use in select high-risk ASD with PH; leaves open randomized confirmation before practice change.
Bruch et al. (2007) studied Atrial septal defect with pulmonary hypertension and/or right heart failure (n=15). Fenestrated Amplatzer septal occluder was evaluated on Complications during device implantation. Fenestrated Amplatzer septal occluder implantation was safely accomplished with 0% complications in 15 high-risk ASD patients, improving NYHA class and decreasing pulmonary artery pressure.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: